How cocaine dealers are beating Covid lockdowns: Drug dealers took to the internet, launching ‘home delivery services’ to prevent a slump in trade during the pandemic, experts warn
- Drug dealers went online and launched ‘home delivery services’ during pandemic
- Drugs are sold with a higher potency, allowing for more overdoses
- The report also found that more forms of cannabis were being sold
Drug dealers have gone online and launched “home delivery services” during the pandemic, experts warn.
The EU’s drug control agency said the supply of illicit narcotics “has not been seriously affected” by the global crisis.
Drugs such as cocaine are sold with higher potency, leading to more overdoses and increasing addictions, according to the report of the European Monitoring Center for Drugs and Drug Addiction.
It added: “While street drug retailing was disrupted during the initial lockdowns and some local shortages were encountered, drug sellers and buyers appear to have adapted by making greater use of encrypted messaging services, social media applications, online resources and mail and home delivery services.’
Drug dealers have gone online and launched ‘home delivery services’ amid the pandemic, experts warn as a report says drugs like higher potency cocaine are being sold, leading to more overdoses and rising addiction (stock image)
It also said that ‘social distancing measures… [may have accelerated] the trend that we have seen in recent years, whereby the market is increasingly involved digitally.’
The report also found that more forms of cannabis were being sold and that sellers were more likely to adulterate natural products with synthetic cannabinoids.
Dame Carol Black, former president of the Royal College of Physicians, told a conference last year that “it wouldn’t be too far to say it’s almost — for some drugs — as easy as getting your pizza.”
In the midst of the first lockdown in May last year, the international police station Interpol warned drug dealers in countries across Europe masquerading as takeaway and supermarket deliverers to distribute drugs door-to-door.
It is the first time the EU drug monitoring agency’s report has not discussed the UK in depth – because of Brexit.